Should I buy or sell RadNet stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" RDNT shares. View RDNT analyst ratings or view top-rated stocks .

What is RadNet's stock price target for 2024?

3 brokers have issued 1 year target prices for RadNet's stock. Their RDNT share price targets range from $48.00 to $58.00. On average, they predict the company's stock price to reach $53.67 in the next twelve months. This suggests a possible upside of 12.3% from the stock's current price. View analysts price targets for RDNT or view top-rated stocks among Wall Street analysts .

How have RDNT shares performed in 2024?

RadNet's stock was trading at $34.77 at the beginning of the year. Since then, RDNT stock has increased by 37.5% and is now trading at $47.80. View the best growth stocks for 2024 here .

When is RadNet's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our RDNT earnings forecast .

How were RadNet's earnings last quarter?

RadNet, Inc. (NASDAQ:RDNT) announced its quarterly earnings data on Friday, March, 1st. The medical research company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.09. The medical research company earned $420.38 million during the quarter, compared to analysts' expectations of $410.11 million. RadNet had a trailing twelve-month return on equity of 4.72% and a net margin of 0.19%. The company's revenue was up 9.5% on a year-over-year basis. During the same period last year, the company posted $0.11 earnings per share.

What ETFs hold RadNet's stock?

ETFs with the largest weight of RadNet (NASDAQ:RDNT) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH) , SPDR S&P Health Care Services ETF (XHS) , Invesco Dorsey Wright Healthcare Momentum ETF (PTH) , Invesco S&P SmallCap Momentum ETF (XSMO) , First Trust Small Cap Growth AlphaDEX Fund (FYC) and SPDR S&P 600 Small Cap Growth ETF (SLYG) . iShares U.S. Healthcare Providers ETF (IHF) .

What guidance has RadNet issued on next quarter's earnings?

RadNet updated its FY 2024 earnings guidance on Thursday, February, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.7 billion-$1.7 billion, compared to the consensus revenue estimate of $1.7 billion.

What is Howard G. Berger's approval rating as RadNet's CEO?

174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com . Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of RadNet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD) , AbbVie (ABBV) , Inovio Pharmaceuticals (INO) , NVIDIA (NVDA) , OPKO Health (OPK) , Boeing (BA) , Rigel Pharmaceuticals (RIGL) , UnitedHealth Group (UNH) , Pfizer (PFE) and AT&T (T) .

Who are RadNet's major shareholders?

RadNet's stock is owned by many different retail and institutional investors. Top institutional investors include Contravisory Investment Management Inc. (0.01%) and Los Angeles Capital Management LLC (0.01%). Insiders that own company stock include Christine Nayoma Gordon, David L Swartz , Lawrence L Levitt , Michael N Murdock , Norman R Hames and Ruth Louisa Villigerwilson . View institutional ownership trends .

How do I buy shares of RadNet?

Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:RDNT

RadNet (RDNT) Stock Price, News & Analysis

→ [Urgent!] Generational Wealth Gameplan (From Crypto 101 Media) (Ad)

Free RDNT Stock Alerts

$47.80

-0.09 (-0.19%)

(As of 04/17/2024 ET)

Compare

Today's Range: $47.56
▼
$48.46
50-Day Range: $35.70
▼
$49.23
52-Week Range: $25.11
▼
$49.94

Volume: 405,896 shs
Average Volume: 525,718 shs
Market Capitalization: $3.27 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $53.67

Get RadNet alerts:

RadNet MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.67 Rating Score
Upside/Downside: 12.3% Upside
$53.67 Price Target
Short Interest: Bearish
4.32% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.52
Upright™ Environmental Score
News Sentiment: 0.35
Based on 8 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 48.57%
From $0.35 to $0.52 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.57 out of 5 stars

Medical Sector

257th out of 913 stocks

Medical Laboratories Industry

8th out of 19 stocks

2.3

Analyst's Opinion

Consensus Rating
RadNet has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
RadNet has only been the subject of 3 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
4.32% of the outstanding shares of RadNet have been sold short.
Short Interest Ratio / Days to Cover
RadNet has a short interest ratio ("days to cover") of 5.4.
Change versus previous month
Short interest in RadNet has recently increased by 6.86%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
RadNet does not currently pay a dividend.
Dividend Growth
RadNet does not have a long track record of dividend growth.

4.6

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
RadNet has received a 72.34% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Mammography services ", "Nuclear medicine imaging services", and "MRI services" products. See details.
Environmental Sustainability
The Environmental Impact score for RadNet is -0.52.

1.9

News and Social Media Coverage

News Sentiment
RadNet has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 8 news articles for RadNet this week, compared to 3 articles on an average week.
Search Interest
Only 5 people have searched for RDNT on MarketBeat in the last 30 days. This is a decrease of -58% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added RadNet to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, RadNet insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 4.43% of the stock of RadNet is held by insiders.
Percentage Held by Institutions
77.90% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for RadNet are expected to grow by 48.57% in the coming year, from $0.35 to $0.52 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of RadNet is -2,388.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of RadNet is -2,388.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
RadNet has a P/B Ratio of 4.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Crypto 101 Media

[Urgent!] Generational Wealth Gameplan

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide

About RadNet Stock (NASDAQ:RDNT)

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

RDNT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RDNT Stock News Headlines

April 17, 2024 | finance.yahoo.com

RadNet, Inc. (RDNT)

April 13, 2024 | americanbankingnews.com

RadNet (NASDAQ:RDNT) Rating Lowered to Sell at StockNews.com

April 18, 2024 | Crypto 101 Media (Ad)

[Urgent!] Generational Wealth Gameplan

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

April 12, 2024 | globenewswire.com

RadNet Teams Up with Basketball Icon Sheryl Swoopes to Promote Healthcare Equity and Access

April 11, 2024 | investing.com

RadNet expands Houston footprint with new acquisition

April 11, 2024 | msn.com

RadNet prices and upsizes refinancing transactions

April 11, 2024 | globenewswire.com

RadNet Announces Pricing and Upsizing of its Previously Announced Term Loan and Revolving Credit Facility Refinancing Transaction

April 10, 2024 | finance.yahoo.com

Does RadNet (RDNT) Have a Long Runway for Growth?

April 18, 2024 | Crypto 101 Media (Ad)

[Urgent!] Generational Wealth Gameplan

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

April 10, 2024 | globenewswire.com

RadNet to Make its Second Acquisition in Houston, Texas

April 8, 2024 | finance.yahoo.com

With 74% ownership, RadNet, Inc. (NASDAQ:RDNT) boasts of strong institutional backing

April 3, 2024 | seekingalpha.com

RadNet proposes refinancing its term loan and revolving credit facility

April 3, 2024 | globenewswire.com

RadNet Announces a Proposed Refinancing of its Term Loan and Revolving Credit Facility

April 2, 2024 | globenewswire.com

RadNet Announces Outpatient Radiology Partnership with Providence Health System to Include Seven Centers in Burbank, Santa Clarita and the Northern San Fernando Valley of Los Angeles

March 28, 2024 | markets.businessinsider.com

What 4 Analyst Ratings Have To Say About RadNet

March 23, 2024 | finance.yahoo.com

At US$48.04, Is It Time To Put RadNet, Inc. (NASDAQ:RDNT) On Your Watch List?

March 16, 2024 | finance.yahoo.com

RDNT Apr 2024 35.000 put

March 16, 2024 | finance.yahoo.com

RDNT Apr 2024 35.000 call

March 12, 2024 | globenewswire.com

RadNet Announces Closing of Public Offering of Common Stock

March 8, 2024 | msn.com

RadNet announces pricing of public offering

March 7, 2024 | globenewswire.com

RadNet Announces Pricing of Public Offering of Common Stock

March 7, 2024 | globenewswire.com

RadNet Announces Proposed $200 Million Underwritten Public Offering of Common Stock

March 6, 2024 | realmoney.thestreet.com

RadNet initiated with neutral view at Barclays

March 5, 2024 | finance.yahoo.com

RadNet, Inc. (NASDAQ:RDNT) Q4 2023 Earnings Call Transcript

March 5, 2024 | globenewswire.com

RadNet, Inc. to Present at the 44th Annual Cowen & Company Healthcare Conference on Wednesday, March 6th

March 4, 2024 | markets.businessinsider.com

Analysts Are Bullish on Top Healthcare Stocks: Sotera Health (SHC), Radnet (RDNT)

March 4, 2024 | globenewswire.com

RadNet, Inc. to Present at the Raymond James 45th Annual Institutional Investors Conference Today, March 4th, 2024

See More Headlines

Receive RDNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/01/2024
Today: 4/17/2024
Next Earnings (Estimated): 5/14/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Medical laboratories
Sub-Industry: N/A
Current Symbol: NASDAQ:RDNT
CUSIP: N/A
CIK: 790526
Web: www.radnet.com
Phone: (310) 445-2800
Fax: 310-445-2980
Employees: 10,288
Year Founded: 1980

Price Target and Rating

Average Stock Price Target: $53.67
High Stock Price Target: $58.00
Low Stock Price Target: $48.00
Potential Upside/Downside: +12.3%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.67
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.02)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 136.57
P/E Growth: N/A
Net Income: $3.04 million
Net Margins: 0.19%
Pretax Margin: 2.40%
Return on Equity: 4.72%
Return on Assets: 1.29%

Debt

Debt-to-Equity Ratio: 1.00
Current Ratio: 1.32
Quick Ratio: 1.32

Sales & Book Value

Annual Sales: $1.62 billion
Price / Sales: 2.02
Cash Flow: $3.33 per share
Price / Cash Flow: 14.35
Book Value: $11.79 per share
Price / Book: 4.05

Miscellaneous

Outstanding Shares: 68,470,000
Free Float: 65,442,000
Market Cap: $3.27 billion
Optionable: Optionable
Beta: 1.69

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Dr. Howard G. Berger M.D. (Age 78)
Chairman, President & CEO
Comp: $5.56M
Mr. Mark D. Stolper (Age 53)
Executive VP & CFO
Comp: $1.13M
Mr. Mital Patel (Age 38)
Executive VP of Financial Planning & Analysis and Chief Administrative Officer
Comp: $1.15M
Mr. Norman R. Hames (Age 68)
President & COO of Western Operations
Comp: $1.28M
Mr. Stephen M. Forthuber (Age 63)
President & COO of Eastern Operations
Comp: $1.3M
Ms. Christine Nayoma Gordon (Age 61)
Senior VP of Operations - Northern California & Director
Comp: $384.38k
Mr. Ranjan Jayanathan (Age 68)
Executive VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division
Dr. Gregory Sorensen M.D. (Age 62)
Executive VP, Chief Science Officer & Director
Ms. Laura Foster BSRT
MPH, J.D., Senior Vice President of Compliance & Regulatory Affairs
Mr. David Jeffrey Katz (Age 59)
Executive VP, Chief Legal Officer & Corporate Secretary

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

RDNT Stock Analysis - Frequently Asked Questions

Should I buy or sell RadNet stock right now?: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" RDNT shares.
View RDNT analyst ratings or view top-rated stocks.
What is RadNet's stock price target for 2024?: 3 brokers have issued 1 year target prices for RadNet's stock. Their RDNT share price targets range from $48.00 to $58.00. On average, they predict the company's stock price to reach $53.67 in the next twelve months. This suggests a possible upside of 12.3% from the stock's current price.
View analysts price targets for RDNT or view top-rated stocks among Wall Street analysts.
How have RDNT shares performed in 2024?: RadNet's stock was trading at $34.77 at the beginning of the year. Since then, RDNT stock has increased by 37.5% and is now trading at $47.80.
View the best growth stocks for 2024 here.
When is RadNet's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our RDNT earnings forecast.
How were RadNet's earnings last quarter?: RadNet, Inc. (NASDAQ:RDNT) announced its quarterly earnings data on Friday, March, 1st. The medical research company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.09. The medical research company earned $420.38 million during the quarter, compared to analysts' expectations of $410.11 million. RadNet had a trailing twelve-month return on equity of 4.72% and a net margin of 0.19%. The company's revenue was up 9.5% on a year-over-year basis. During the same period last year, the company posted $0.11 earnings per share.
What ETFs hold RadNet's stock?: ETFs with the largest weight of RadNet (NASDAQ:RDNT) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), Invesco Dorsey Wright Healthcare Momentum ETF (PTH), Invesco S&P SmallCap Momentum ETF (XSMO), First Trust Small Cap Growth AlphaDEX Fund (FYC) and SPDR S&P 600 Small Cap Growth ETF (SLYG).iShares U.S. Healthcare Providers ETF (IHF).

What guidance has RadNet issued on next quarter's earnings?: RadNet updated its FY 2024 earnings guidance on Thursday, February, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.7 billion-$1.7 billion, compared to the consensus revenue estimate of $1.7 billion.
What is Howard G. Berger's approval rating as RadNet's CEO?: 174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of RadNet own?: Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T).
Who are RadNet's major shareholders?: RadNet's stock is owned by many different retail and institutional investors. Top institutional investors include Contravisory Investment Management Inc. (0.01%) and Los Angeles Capital Management LLC (0.01%). Insiders that own company stock include Christine Nayoma Gordon, David L Swartz, Lawrence L Levitt, Michael N Murdock, Norman R Hames and Ruth Louisa Villigerwilson.
View institutional ownership trends.
How do I buy shares of RadNet?: Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:RDNT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

RadNet (RDNT) Stock Price, News & Analysis

RadNet MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About RadNet Stock (NASDAQ:RDNT)

RDNT Stock Price History

RDNT Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

RDNT Stock Analysis - Frequently Asked Questions

Overall MarketRank^™